Jnj

From FeedX

Enter your search terms Web feedx.net Submit search form

• papal_plane michel_veillette reliance_india_call ponderthemonder monroe_sex_tape jnj b93 where_do_i_mail_my_taxes extension_site_irs_gov himitsu_desu

[edit] Global Investing Roundups, Tuesday, December 2nd, 2008

2 December 2008, by NBER: U.S. in Recession Since Dec. 2007; Fed Reserve Could Buy T-Bills; JP Morgan Sees 0% Interest Rates; Pilgrim’s Pride Files for Bankruptcy Protection; Consumer Credit Crunch in the Making; Crude Slides on Recession Outlook; J&J to Buy Mentor It’s official: The United States has been in a recession since December 2007, the National Bureau of Economic Research said yesterday (Monday). Already 12 months into it, this recession is longer than eight of the 10 recessions the U.S. has experie

[edit] Citi Maintains a 'Buy' Rating on Johnson & Johnson (JNJ), Says ... - StreetInsider.com (subscription)

2 December 2008, by

[edit] Standard & Poors: Johnson & Johnson kopen.

2 December 2008, by (Analist.nl) New York - Op 2-12-2008 herhaalt analist Herman Saftlas van Standard & Poors zijn koopadvies voor de Amerikaanse producent van verzorgingsproducten Johnson & Johnson (ISIN: US4781601046 / Symbol: JNJ).nnHet 12-maands koersdoel voor Johnson & Johnson.. (lees verder op: ...

[edit] Cash-Rich Companies Could Be Ready to Merge

2 December 2008, by As market valuations get crushed, here are some likely buyers and targets.

[edit] Nine Pharma Predictions for 2009

2 December 2008, by Time to pen our predictions for our beats in the new year. With each passing year, though, this assignment is becoming more of a challenge. Seven predictions for 2007...doable. Eight for '08...alright, I guess I can handle that. Nine for '09...we're starting to push it. But here goes. 1. Big Pharma M & A

[edit] Stocks in the news: C, BAC, TGT, CPB, S, RIMM, AAPL, TASR, SPWRA, NYT (update)

2 December 2008, by Stocks in the news: C, BAC, TGT, CPB, S, RIMM, AAPL, TASR, SPWRA, NYT (update) Posted by: in Latest News Filed under: Earnings reports, Deals, Apple Inc (AAPL), Hewlett-Packard (HPQ), Citigroup Inc. (C), Target Corp. (TGT), Johnson and Johnson (JNJ), New York Times’A’ (NYT), Sprint Nextel Corp (S), Bank of America (BAC), Campbell Soup (CPB), Research in Motion (RIMM), Taser Intl Inc (TASR) Citigroup Inc. (NYSE: C) is getting a $20 billion government injection as part of a rescue package t

[edit] Plastic industry market news: Bet on TA with JJ (JNJ) - BloggingStocks

2 December 2008, by unknown Bet on T&A with J&J (JNJ)BloggingStocks - 2 hours agoThey have their pulse on the market and a copy of Shape magazine on their desk. As the baby-boomer generation ages, plastic surgery looks to be a huge ......

[edit] 2nd UPDATE:J&J To Buy Breast-Implant Maker Mentor For $1.07 Billion ...

1 December 2008, by By Jon Kamp Johnson & Johnson (JNJ) agreed to acquire breast-implant maker Mentor Corp. ( MNT) for $1.07 billion , a rare 10-figure deal these days that will boost J&J's aesthetic product offerings while ratcheting up competition with Allergan Inc.

[edit] Bet on T&A with J&J (JNJ) | Macroaxis Blog :: Investing to Wealth

1 December 2008, by unknown Taking advantage of a strong balance sheet and rich cash flow, JNJ is a winner in this economy. Self-image issues aside, I like this deal. Jamie Dlugosch is a contributor to InvestorPlace.com.Bet on T&A with J&J (JNJ) originally ...

[edit] Johnson & Johnson to acquire Mentor - MarketWatch

1 December 2008, by

[edit] Is Allergan Worth More or Less After J&J Buys Mentor? (MNT, JNJ ...

1 December 2008, by unknown You have probably heard about the acquisition where Johnson & Johnson (NYSE: JNJ) is acquiring Mentor Corp. (NYSE: MNT). Frankly, now that we took a look this deal is not at all that surprising and we are not that surprised that the ...

[edit] Bet on T&A with J&J (JNJ) - BloggingStocks

1 December 2008, by

[edit] Bet on T&A with J&J (JNJ) - BloggingStocks

1 December 2008, by unknown A premium price of that magnitude in this market environment is hard to believe, but I would not bet against JNJ here. They have their pulse on the market and a copy of Shape magazine on their desk. As the baby-boomer generation ages, ...

[edit] Is Allergan Worth More or Less After J&J Buys Mentor? (MNT, JNJ, AGN)

1 December 2008, by Is Allergan Worth More or Less After J&J Buys Mentor? (MNT, JNJ, AGN) December 1, 2008 · Filed Under General · Comments Off You have probably heard about the acquisition where Johnson & Johnson (NYSE: JNJ) is acquiring Mentor Corp. (NYSE: MNT).  Frankly, now that we took a look this deal is not at all that surprising and we are not that surprised that the $31.00 is nearly a 100% premium to Friday’s price of Mentor.  But what is surprising is that the merger is putting severe pressure tod

[edit] Bet on T&A with J&J (JNJ)

1 December 2008, by Filed under: Deals, Good news, Newsletters, Johnson and Johnson (JNJ), Stocks to Buy Over the long holiday weekend, I had a chance to do some much needed reading. Given my vocation, sometimes I like to read articles that have little to do with the markets or finance as a way of recharging my batteries. Of course, even when I partake in this guilty pleasure, there really is no way to truly escape. Somehow every story has a link or relationship to investing that I can utilize in my stock-picking

[edit] Основные биржевые индексы снизились на Wall Street в первый день декабря

1 December 2008, by Так же сегодня мы увидим отчеты MWY (midway games) и JnJ (Johnson and Johnson).

[edit] Johnson & Johnson (JNJ) buying Mentor (MNT) a good sign ...

1 December 2008, by unknown JNJ put the price for MNT at $31 per share, more than 90% above Friday's price of $16. This kind of buyout activity could signal a couple things. First JNJ is in pretty good financial shape and second that many stocks are undervalued ...

[edit] UPDATE: J&J To Buy Breast-Implant Maker Mentor For $1.07 Billion - CNNMoney ...

1 December 2008, by Johnson & Johnson (JNJ) has agreed to acquire breast-implant maker Mentor Corp.

[edit] Midday Market Update: Dow Plunges More Than 410 Points on Weak ... - Schaeffers Research

1 December 2008, by

[edit] J&J: Now Master Over Mentor (MNT, JNJ) - NYSE, Mongolian tugrug ...

1 December 2008, by unknown J&J: Now Master Over Mentor (MNT, JNJ) - If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium ...

[edit] Notable Mergers and Acquisitions of the Day 12/01: JNJ/MNT, AIG ...

1 December 2008, by unknown Johnson & Johnson (NYSE: JNJ) and Mentor Corporation (NYSE: MNT) announced a definitive agreement whereby Mentor will be acquired for approximately $1.07 billion in a cash tender offer. Under the terms of the agreement, ...

[edit] The start of a very odd week - Todays Financial News

1 December 2008, by

[edit] Options Update: General Motors (GM) & Johnson & Johnson (JNJ ...

1 December 2008, by unknown The Options Insider.Com takes you inside the options markets with breaking news, cutting-edge options education and expert analysis of the latest options topics.

[edit] Options Update: General Motors (GM) & Johnson & Johnson (JNJ) - The Options Insider

1 December 2008, by

[edit] Chart Presentation: Macro Revisit - Inside Futures

1 December 2008, by

[edit] Options Update: Johnson & Johnson and Mentor volatility up into ...

1 December 2008, by unknown Johnson & Johnson (NYSE: JNJ) will purchase Mentor (NYSE: MNT) for $31 per share. MNT, a supplier of medical products closed at $16.15 Friday. MNT December option implied volatility of 92 is above its 26-week average of 55 according to ...

[edit] 24/7 Wall St.: J&J: Now Master Over Mentor (MNT, JNJ)

1 December 2008, by unknown Insightful Analysis and Commentary for US and Global Equity Investors.

[edit] J&J: Now Master Over Mentor (MNT, JNJ) - 24/7 Wall St.

1 December 2008, by

[edit] JNJ BTW " Blog Archive " This Week on the Health Channel: Diabetes

30 November 2008, by ehcamw

[edit] JNJ BTW " Blog Archive " McNeil Meets Twitter - We Hear You

30 November 2008, by ehcamw

[edit] JNJ BTW " Blog Archive " From the Heart...

30 November 2008, by ehcamw

[edit] JNJ BTW

30 November 2008, by ehcamw

[edit] J&J's Credo - Life

30 November 2008, by obrun

[edit] The FDA's Killing Bug Killers - Motley Fool

28 November 2008, by

[edit] yt jnj,h

28 November 2008, by yt jnj,h

[edit] Dierickx, Leys & Cie: Johnson & Johnson kopen.

27 November 2008, by (Analist.nl) Antwerpen - Op 27-11-2008 herhalen de analisten van Dierickx, Leys & Cie hun koopadvies voor de Amerikaanse producent van verzorgingsproducten Johnson & Johnson (ISIN: US4781601046 / Symbol: JNJ).nnEen koersdoel wordt niet afgegeven. In 2007 bedroeg de.. (lees verder op: ...

[edit] Dividends: There's No Such Thing as a Free Lunch on Wall Street

27 November 2008, by I've written in the past that dividend investments can be a solid piece of your portfolio. I prefer growth stocks, and in that realm, dividends are basically meaningless. However, with more and more stocks, trusts, exchange-traded funds and the like, there are definitely intelligent ways to invest for yield. Today, however, many investors are looking for certainty in an insanely volatile, uncertain world. And because of that, many people are examining certain financial stocks or trusts that ha

[edit] Chasing Value: Feds single source Intuitive Surgical

27 November 2008, by Chasing Value: Feds single source Intuitive Surgical Posted by: in Products and Services Filed under: International markets, Press releases, Products and services, Competitive strategy, Johnson and Johnson (JNJ), Chasing Value, Stocks to Buy, Intuitive Surgical Inc (ISRG), Technology Yesterday, in response to Chasing Value: ISRG is falling and I’m buying I received the following comment from Beltway Greg, “You’re a brave dude. Why? I’ve watched this stock for a while and I worry about pos

[edit] Johnson & Johnson Is the Latest FDA Casualty

27 November 2008, by Does the Food and Drug Administration approve drugs anymore? Or are we seeing the lame-duck leadership at the agency punt any action over to the next administration? Late Tuesday, the FDA gave Pfizer (PFE) full, formal approval of its new HIV/AIDS drug. But that was only to be followed by news out of Dow component Johnson & Johnson (JNJ) Wednesday morning that the agency can't approve JNJ's new drug for hospital-acquired infections just yet. In early trading, JNJ was the biggest dollar and

[edit] FDA Delay For J&J - Forbes

27 November 2008, by JNJ - news - people ) received a letter from the US Food and Drug Administration that rejected its new drug .

[edit] Why Dividends Beat P/E Ratios

26 November 2008, by Earnings can be massaged or revised, but dividends are tangible and cannot be faked.

[edit] They Just Don't Get JNJ! (TheStreet.com TV)

26 November 2008, by http://us.news2.yimg.com/us.yimg.com/p/fi/19/64/23.jpg/yfinance/tscm/strategysession/10450001http://www.thestreet.com/

[edit] Wary of Chasing the Rally

26 November 2008, by It's hard to find a time when the index put/call ratios were so low but the market kept rising.

[edit] Global Marketing Group

25 November 2008, by cwleecwlee

[edit] Soft Goods Are Hit Hard

25 November 2008, by These names will be back, though, so don't go overboard with the selling.

[edit] Sell Risk, Buy Pharma

25 November 2008, by There is a sketch by comedian Tom Green where he stands outside on the deck of a boat in the middle of a storm and proclaims: “It’s crazy!” However, as the intensity of the storm continues to increase, Green has to repeatedly correct his earlier assessment: “When I said it was crazy [earlier], it wasn’t crazy. Now it’s crazy!” This is how many value investors must have felt about the market this year. I know I did. Back in May, I wrote an article for Seeking Alpha where I essentially alleged t

[edit] Cramer: When to Buy JNJ and Mickey D's (TheStreet.com TV)

25 November 2008, by http://us.news2.yimg.com/us.yimg.com/p/fi/19/61/60.jpg/yfinance/tscm/cramermarketupdates/10449804http://www.thestreet.com/

[edit] Strategically Managing Your Dividend Portfolio During a Downturn

25 November 2008, by The recent turbulence in the market has provided many income investors first hand experience in managing their income portfolio in a declining market. For some, this may be their first significant and prolonged downturn. Here are some things that will help you succeed and thrive during this bear market: I. Remember Why You Are An Income Investor The goals of an income portfolio are different than those of a capital appreciation based portfolio. The good news is an income portfolio consisting

[edit] Wall Street Breakfast: Must-Know News

25 November 2008, by Consumers to get new loan program. The Treasury and Federal Reserve are working on a new facility to boost consumer financing, and could unveil the initiative as early as today. Sources say the Treasury and the Fed will help fund new loans packaged into securities for sale to investors, using $25B-$100B from the $700B TARP program. The facility, which will be operated by the Fed, aims to increase the availability of auto loans, student loans and credit cards, but could eventually be expanded t

[edit] ABN AMRO: Johnson & Johnson kopen.

25 November 2008, by (Analist.nl) Amsterdam - Op 25-11-2008 brengen de analisten van ABN AMRO een koopadvies uit voor de Amerikaanse producent van verzorgingsproducten Johnson & Johnson (ISIN: US4781601046 / Symbol: JNJ).nnEen koersdoel wordt niet afgegeven. In 2007 bedroeg de.. (lees verder op: www.analist.nl) ...